Showing results (91-100 of 199) with videos related to
Sort By:
Pageof 20
Journal of Visualized Experiments : Jove|January 17, 2014
Optimization of high grade glioma cell culture from surgical specimens for use in clinically relevant animal models and 3D immunochemistryLaura A Hasselbach, Susan M Irtenkauf, Nancy W Lemke, et al.Magnetic Resonance Imaging|September 10, 2017
Reproducibility and relative stability in magnetic resonance imaging indices of tumor vascular physiology over a period of 24h in a rat 9L gliosarcoma modelTavarekere N Nagaraja, Rasha Elmghirbi, Stephen L Brown, et al.International Journal of Cancer|February 10, 2009
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependencyTom Mikkelsen, Chaya Brodie, Susan Finniss, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideStuart A Grossman, Kathryn A Carson, Tracy T Batchelor, et al.Oncotarget|April 4, 2013
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewalHae Kyung Lee, Susan Finniss, Simona Cazacu, et al.Plos One|December 31, 2013
Cilengitide-induced temporal variations in transvascular transfer parameters of tumor vasculature in a rat glioma model: identifying potential MRI biomarkers of acute effectsTavarekere N Nagaraja, Madhava P Aryal, Stephen L Brown, et al.Oncotarget|August 13, 2015
RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loopNis David Giladi, Amotz Ziv-Av, Hae Kyung Lee, et al.Neuro-Oncology|January 19, 2013
NABTT 0502: a phase II and pharmacokinetic study of erlotinib and sorafenib for patients with progressive or recurrent glioblastoma multiformeDavid M Peereboom, Manmeet S Ahluwalia, Xiaobu Ye, et al.NMR in Biomedicine|August 16, 2014
Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 gliomaMadhava P Aryal, Tavarekere N Nagaraja, Stephen L Brown, et al.Journal of Neuro-Oncology|May 8, 2010
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomasDavid M Peereboom, Jeffrey G Supko, Kathryn A Carson, et al.Pageof 20